🔎 Trials Near Me

Beranda › Diabetes Tipe 2 › Minnesota

Uji klinis Diabetes Tipe 2 di Minnesota

17 studi untuk Diabetes Tipe 2 mencari peserta di lokasi di Minnesota.

Kota di Minnesota

Teks studi resmi (Bahasa Inggris)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  • Essentia Institute of Rural Health, Duluth
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06906640

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  • Essentia Health, Duluth
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06906627

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • International Diabetes Center, Minneapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07564414

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • International Diabetes Center, Minneapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Minneapolis Heart Institute Foundation, Minneapolis
Menerima pesertaSukarelawan sehat diterima
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06112418

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Mankato
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • AES - DRS - Synexus Clinical Research US, Inc. - Edina - Minneapolis, Edina
  • Mankato Clinic - East Main Street - Javara - PPDS, Mankato
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07340320

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Minneapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07662213

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Health Partners, Minneapolis
Menerima peserta
Usia 14 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07579702

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • International Diabetes Center, Minneapolis
  • Mayo Clinic, Rochester
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07521475

Individualized Diabetes Education Assisted by CGM (IDEA-CGM)

  • University of Minnesota, Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06784375

Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)

  • University of Minnesota, Minneapolis
Menerima peserta
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT07524205

A Study of Glycemic Control in Left Ventricular Assist

  • Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT05933161

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

  • Mayo Clinic in Rochester, Rochester
Menerima pesertaFase 2
Usia 25 hingga 70 · Semua jenis kelamin · Diperbarui 14 Okt 2025 · NCT06976619

Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management

  • Hennepin Healthcare Research Institute, Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2025 · NCT07091487

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.